BIOLINERX AND HEMISPHERIAN PRESENT PRECLINICAL DATA DEMONSTRATING SYNERGY OF GLIX1 WITH PARP INHIBITORS IN HR-PROFICIENT OVARIAN CANCER AT ESMO 2026

Reuters · 3d ago

Please log in to view news